Relief Therapeutics Holding SA — Form D
Relief Therapeutics Holding SA of CH-1202 GENEVA, V8, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-25. The offering totals $16.4M, of which $16.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-08-25
- Form: D
- Accession: 0001854078-21-000003
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $16.4M
- Amount sold: $16.4M
- Minimum investment: $16.4M
- Investors: 1
- Date of first sale: 2021-07-28
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-411279
Issuer
- Name: Relief Therapeutics Holding SA
- CIK: 0001854078
- Entity type: Corporation
- Jurisdiction: SWITZERLAND
- Address: AVENUE DE SECHERON 15, CH-1202 GENEVA, V8, NA
- Phone: 914-672-3555
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Paolo Galfetti | Director | CH-1202 Geneva, V8 |
| Patrice Jean | Director | CH-1202 Geneva, V8 |
| Tom Plitz | Director | CH-1202 Geneva, V8 |
| Raghuram Selvaraju | Director | CH-1202 Geneva, V8 |
| Gilles Della Corte | Executive Officer | CH-1202 Geneva, V8 |
| Taneli Jouhikainen | Executive Officer | CH-1202 Geneva, V8 |
| Chris Stinjen | Executive Officer | CH-1202 Geneva, V8 |
| Jack Weinstein | Executive Officer | CH-1202 Geneva, V8 |
| Raghuram Selvaraju | Executive Officer | CH-1202 Geneva, V8 |
| Chris Stijnen | Executive Officer | CH-1202 Geneva, V8 |
Other filings by this issuer (1)
More